PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2020.35.2.3672020352367-376Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying TreatmentsYe Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choihttp://e-enm.org/upload/pdf/EnM-2020-35-2-367.pdf, http://e-enm.org/journal/view.php?doi=10.3803/EnM.2020.35.2.367, http://e-enm.org/upload/pdf/EnM-2020-35-2-367.pdf
Atherosclerosis10.1016/j.atherosclerosis.2014.05.86820142352e289Lipid target achievement among patients according to ESC/EAS and ACC/AHA guidelines in a lipid clinicH. Milionis, F. Barkas, E. Liberopoulos, M. Kostapanos, E. Klouras, M. Elisafhttps://api.elsevier.com/content/article/PII:S0021915014011046?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915014011046?httpAccept=text/plain
Atherosclerosis10.1016/j.atherosclerosis.2011.09.0422012220142-44News from the literature: Focus on joint ESC/EAS dyslipidemia guidelinesJane Stockhttps://api.elsevier.com/content/article/PII:S0021915011009488?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915011009488?httpAccept=text/plain
Atherosclerosis10.1016/j.atherosclerosis.2021.05.0132021EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patientsJane K. Stockhttps://api.elsevier.com/content/article/PII:S0021915021002495?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915021002495?httpAccept=text/plain
International Journal of Cardiology10.1016/j.ijcard.2020.05.0552020316229-235Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registryLeonardo De Luca, Marcello Arca, Pier Luigi Temporelli, Jennifer Meessen, Carmine Riccio, Paolo Bonomo, Angela Rita Colavita, Domenico Gabrielli, Michele Massimo Gulizia, Furio Colivicchihttps://api.elsevier.com/content/article/PII:S0167527320319495?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167527320319495?httpAccept=text/plain
Journal of Lipid and Atherosclerosis10.12997/jla.2015.4.1.61201541612015 Korean Guidelines for Management of Dyslipidemia https://synapse.koreamed.org/DOIx.php?id=10.12997/jla.2015.4.1.61, https://synapse.koreamed.org/pdf/10.12997/jla.2015.4.1.61, https://e-jla.org/Synapse/Data/PDFData/9992JLA/jla-4-61.pdf
European Heart Journal10.1093/eurheartj/ehz826201941444255-4255Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskhttp://academic.oup.com/eurheartj/article-pdf/41/44/4255/34827866/ehz826.pdf, http://academic.oup.com/eurheartj/article-pdf/41/44/4255/34827866/ehz826.pdf
Revista Española de Cardiología (English Edition)10.1016/j.rec.2020.04.00620207354032019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular riskhttps://api.elsevier.com/content/article/PII:S1885585720301663?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1885585720301663?httpAccept=text/plain
European Heart Journal10.1093/ehjci/ehaa946.3003202041Supplement_2What is the potential cardiovascular risk reduction associated with achieving LDL-C levels recommended in the ESC/EAS guidelines for very high-risk patients? Data from 18 European countriesK.K Ray, S Bray, A.L Catapano, N Poulter, G Villahttp://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3003/34521261/ehaa946.3003.pdf, http://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3003/34521261/ehaa946.3003.pdf
Journal of Pharmaceutical Health Services Research10.1111/jphs.123712020114423-427Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 GuidelinesEman N Alhmoud, Raja Barazi, Amr Fahmi, Abdullah Abdu, Alya Higazy, Maguy ElHajjhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjphs.12371, https://onlinelibrary.wiley.com/doi/pdf/10.1111/jphs.12371, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jphs.12371, http://academic.oup.com/jphsr/article-pdf/11/4/423/36284397/jphs12371.pdf, http://academic.oup.com/jphsr/article-pdf/11/4/423/36284397/jphs12371.pdf